T43.3X2 Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm

Name of the Condition

• Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm
• Technical term: T43.3X2

Summary

This condition refers to intentional self-harm resulting from exposure to phenothiazine antipsychotics and neuroleptic medications. These drugs are used to treat psychiatric disorders such as schizophrenia, bipolar disorder, and severe agitation. Intentional self-harm may involve deliberate overdose or misuse of these medications.

Causes

Intentional self-harm can result from deliberate ingestion of an excessive dose, misuse of prescribed medications, or intentional exposure to these drugs. It may be associated with underlying psychiatric conditions, emotional distress, or suicidal ideation. Documentation should reflect the intentional nature of the exposure.

Risk Factors

• Underlying psychiatric disorders (e.g., depression, schizophrenia).
• History of suicidal behavior or ideation.
• Access to medications without supervision.
• Social or emotional stressors.
• Substance use disorders.

Symptoms

Symptoms may include drowsiness, confusion, dizziness, rapid heart rate, low blood pressure, muscle stiffness, or seizures. Gastrointestinal effects like nausea, vomiting, or abdominal pain may also occur. Severe cases can lead to respiratory depression or coma.

Diagnosis

Diagnosis is based on clinical presentation, patient history, and documentation of intentional self-harm. Laboratory tests may confirm drug levels, and imaging or other assessments may evaluate organ function. Documentation must clearly indicate the intentional nature of the exposure.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing underlying psychiatric needs. This may include activated charcoal, supportive care, or antidotes if available. Psychiatric evaluation and intervention are critical for long-term management.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning and timely intervention. Follow-up care should include psychiatric assessment, medication review, and support for mental health. Ongoing monitoring is essential to prevent recurrence.

Complications

Complications may include organ damage (e.g., liver or kidney), respiratory failure, or prolonged sedation. Severe cases can result in permanent disability or death. Psychiatric complications, such as recurrent suicidal behavior, may also occur.

Lifestyle & Prevention

Prevention involves secure medication storage, patient education on safe use, and addressing underlying mental health conditions. Support systems and crisis intervention resources can reduce risk. Regular psychiatric follow-up is recommended.

When to Seek Professional Help

Seek immediate medical attention if intentional self-harm is suspected or if symptoms of poisoning (e.g., drowsiness, confusion, seizures) are present. Prompt care is critical to minimize harm and address underlying issues.

Tips for Medical Coders

Use T43.3X2 when the documentation specifies intentional self-harm from phenothiazine antipsychotics or neuroleptics. Ensure the intent is clearly documented, as this distinguishes it from accidental or undetermined poisoning. Verify the drug class and intentional nature to apply the code accurately.